VERRUCOUS ORAL LEUKOPLAKIA

Clinical trials for VERRUCOUS ORAL LEUKOPLAKIA explained in plain language.

Never miss a new study

Get alerted when new VERRUCOUS ORAL LEUKOPLAKIA trials appear

Sign up with your email to follow new studies for VERRUCOUS ORAL LEUKOPLAKIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immunotherapy tackles precancerous mouth spots

Disease control Recruiting now

This trial tests whether pembrolizumab (Keytruda), an immunotherapy drug that helps the immune system attack abnormal cells, can shrink or control leukoplakia—a precancerous condition of the mouth. The study includes people with leukoplakia or related lesions that cannot be remov…

Matched conditions: VERRUCOUS ORAL LEUKOPLAKIA

Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

VERRUCOUS ORAL LEUKOPLAKIA

Get alerted when new VERRUCOUS ORAL LEUKOPLAKIA trials appear

Immunotherapy tackles precancerous mouth spots